Caplin Point Laboratories Ltd. NSE: CAPLIPOINT | BSE: 524742

Mid-range Performer

In 1 Starfolio Basket

Download real time

1926.90 19.30 (1.01%)

27.04% Fall from 52W High

26,478

NSE+BSE Volume

NSE 19 Dec, 2025 3:31 PM (IST)

Revenue Guidance

Caplin Point guides for revenue growth to pick up from FY28, led by US and Latin America expansion See details

Caplin Point Labs News and Updates

Name: Latest research reports of Caplin Point Laboratories Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Caplin Point Laboratories Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news on Caplin Point Labs from all sources in a single place.

Load latest

Is Caplin Point Laboratories Ltd. worth buying?

489 Votes:

Buy 80.78%

Sell 12.27%

Hold 6.95%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf